Antiproteases and retinoids for treatment of chronic obstructive pulmonary disease

Author： Donnelly Louise E   Rogers Duncan F  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.13, Iss.9, 2003-09, pp. : 1345-1372

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aclidinium bromide for the treatment of chronic obstructive pulmonary disease

By Cazzola Mario   Page Clive P   Matera Maria Gabriella  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 9, 2013-06 ,pp. : 1205-1214

Informa Healthcare

Access to resources Recommend Favorite

Levosalbutamol for chronic obstructive pulmonary disease: a treatment evaluation

By Patel Manish   Thomson Neil C  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 7, 2012-05 ,pp. : 1069-1075

Informa Healthcare

Access to resources Recommend Favorite

Indacaterol maleate for the treatment of chronic obstructive pulmonary disease

By Tashkin Donald P  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 12, 2010-08 ,pp. : 2077-2085

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Chronic Obstructive Pulmonary Disease in Older Patients: A Practical Guide

By Yohannes A.M.  

Drugs & Aging, Vol. 20, Iss. 3, 2003-01 ,pp. : 209-228

Adis International

Access to resources Recommend Favorite

Targeting histone deacetylase 2 in chronic obstructive pulmonary disease treatment

By Barnes Peter J  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 6, 2005-12 ,pp. : 1111-1121

Informa Healthcare

Access to resources Recommend Favorite